Morse Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.89M Sell
10,125
-419
-4% -$111K 0.81% 35
2026
Q1
$1.16M Sell
10,544
-8,852
-46% -$1.26M 0.24% 84
2025
Q4
$3.23M Sell
19,396
-8,398
-30% -$1.4M 0.64% 48
2025
Q3
$5.44M Sell
27,794
-5,834
-17% -$959K 1.09% 27
2025
Q2
$3.04M Buy
33,628
+7,689
+30% +$607K 0.67% 42
2025
Q1
$1.55M Sell
25,939
-4,873
-16% -$451K 0.39% 62
2024
Q4
$4.08M Buy
30,812
+30,742
+43,917% +$2.89M 0.93% 31
2024
Q3
$3.67K Buy
+70
New +$3.29K ﹤0.01% 294

Other funds holding ALAB

Morse Asset Management's ALAB Position: Q2 2026 in Review

Morse Asset Management reduced its Astera Labs (ALAB) stake by 4% in Q2 2026, selling an estimated $111K and leaving 10,125 shares worth $4.89M. The position accounts for 0.81% of the portfolio, ranked #35.

Morse Asset Management first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.44M in Q3 2025. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Morse Asset Management held 10,125 shares of Astera Labs worth $4.89M as of Q2 2026.
  • Morse Asset Management sold 419 Astera Labs shares in Q2 2026, an estimated $111K.
  • Astera Labs made up 0.81% of Morse Asset Management's portfolio in Q2 2026, its #35 holding.
  • Morse Asset Management first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • Morse Asset Management's Astera Labs position peaked at $5.44M in Q3 2025.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Morse Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.